Sandra Leggero has a background in financial markets, having spent more than 9 years in commodities trading for several European and Asian companies. She holds a degree in Economics from the University of Pavia and specializes in emerging markets.
, | Updated:
Key Moments
Eli Lilly received U.S. Food and Drug Administration approval for Onswik, a once-weekly basal insulin for adults with type 2 diabetes.
The company plans to introduce the Onswik KwikPen to the U.S. market in the coming months.
Onswik will be offered in two concentrations: 500 units/mL and 1,000 units/mL.
Regulatory Approval
Eli Lilly has obtained approval from the Food and Drug Administration for Onswik, a once-weekly basal insulin intended for the treatment of adults with type 2 diabetes.
Product Launch and Formulations
According to the company, the Onswik KwikPen is expected to become available in the United States in the coming months. The product will be offered in two distinct concentrations to support dosing flexibility.
Product
Form
Concentrations
Onswik
KwikPen
500 units/mL, 1,000 units/mL
TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.
Related News
Natural gas trading outlook: futures steady on outlook for warmer weather Natural gas was little changed for a second day on Wednesday as investors weighed a heavy inventory withdrawal, likely to be reported on Thursday, against extended forecasts calling for warmer weather across the majority of the US.Natural […]
WTI Slumps as US-Iran Diplomacy Tests Key Resistance Zone Key Moments
WTI futures on NYMEX trade almost 3% lower near $87.60 during the European session on Thursday.
Prices remain capped below the 20-day EMA at $91.52, reinforcing a bearish near-term technical outlook.
Further […]
Vistra Energy Stock Soars to All-Time High of $165.53 Vistra Corp. (NYSE:VST) has reached an all-time high, with its stock price surging 21% in the last 5 days to touch $165.53. This remarkable growth has propelled the company's market capitalization to $56.69 billion, solidifying its position as […]